What does PHARMACIE LABAR do?

PHARMACIE LABAR is a pharmacy in Dinant. Private Limited, started on 21 March 2007, 1 establishment.

What is the address of PHARMACIE LABAR?

The registered office of PHARMACIE LABAR is located at Rue Grande 123, 5500 Dinant.

Is PHARMACIE LABAR still active?

Yes. According to the CBE (29 September 2026) PHARMACIE LABAR is active, legal situation “Normale toestand”, started on 21 March 2007.

Is PHARMACIE LABAR registered on Peppol?

Yes, PHARMACIE LABAR is registered on the Peppol network with ID 0208:0888126753.

What is the enterprise number of PHARMACIE LABAR?

The enterprise number of PHARMACIE LABAR is BE0888126753.

When was PHARMACIE LABAR founded?

PHARMACIE LABAR was founded on 21 March 2007.

Who are the directors of PHARMACIE LABAR?

According to the 2025 annual accounts, the directors of PHARMACIE LABAR are: MARIE-HELENE LABAR.

Is PHARMACIE LABAR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 March 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE LABAR make in 2025?

PHARMACIE LABAR posted a profit after taxes of € 50,713 in financial year 2025.

What is the revenue of PHARMACIE LABAR?

As a small company, PHARMACIE LABAR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 231,494.

How much does an employee at PHARMACIE LABAR earn?

The average wage cost per full-time employee at PHARMACIE LABAR was € 53,400 in 2025: staff costs of € 117,457 for 2.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE LABAR have?

According to the 2025 annual accounts, PHARMACIE LABAR has 2.2 full-time equivalents (FTE).

PHARMACIE LABAR (Private Limited) - Dinant - BE0888126753

Dossier PHARMACIE LABAR, printed on 29 September 2026 from databakkes.be/en/0888126753/pharmacie-labar. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE LABAR from Dinant, company number BE0888126753, closed financial year 2025 with a result of € 50,713 after tax. For that financial year PHARMACIE LABAR recorded a gross margin of € 231,494 and equity of € 691,695. Compared with financial year 2024, the result moved from € 89,070 to € 50,713. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 691,695

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 50,713

▼ 43% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 291,817

▲ 13% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 8,211 paid out

16 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

2.2

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 117,457

▲ 3% vs 2024

€ 53,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 16,417

▼ 31% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 14,559

▼ 27% vs 2024

€ 5,680 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 84,884

▲ 20% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 26,230

▼ 17% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 263,799 Gross margin 2022: € 263,799 First fiscal year in the series	€ 276,000 Gross margin 2023: € 276,000 ▲ 5% vs 2022 (€ 263,799) Favourable step	€ 288,209 Gross margin 2024: € 288,209 ▲ 4% vs 2023 (€ 276,000) Favourable step	€ 231,494 Gross margin 2025: € 231,494 ▼ 20% vs 2024 (€ 288,209) Unfavourable step	▼ 20%
Profit after taxes	€ 82,569 Profit after taxes 2022: € 82,569 First fiscal year in the series	€ 78,849 Profit after taxes 2023: € 78,849 ▼ 5% vs 2022 (€ 82,569) Unfavourable step	€ 89,070 Profit after taxes 2024: € 89,070 ▲ 13% vs 2023 (€ 78,849) Favourable step	€ 50,713 Profit after taxes 2025: € 50,713 ▼ 43% vs 2024 (€ 89,070) Unfavourable step	▼ 43%
Equity	€ 497,695 Equity 2022: € 497,695 First fiscal year in the series	€ 568,333 Equity 2023: € 568,333 ▲ 14% vs 2022 (€ 497,695) Favourable step	€ 649,193 Equity 2024: € 649,193 ▲ 14% vs 2023 (€ 568,333) Favourable step	€ 691,695 Equity 2025: € 691,695 ▲ 7% vs 2024 (€ 649,193) Favourable step	▲ 7%
Total debts	€ 106,085 Total debts 2022: € 106,085 First fiscal year in the series	€ 133,435 Total debts 2023: € 133,435 ▲ 26% vs 2022 (€ 106,085) Unfavourable step	€ 134,243 Total debts 2024: € 134,243 ▲ 1% vs 2023 (€ 133,435) Unfavourable step	€ 137,780 Total debts 2025: € 137,780 ▲ 3% vs 2024 (€ 134,243) Unfavourable step	▲ 3%
Cash	€ 256,926 Cash 2022: € 256,926 First fiscal year in the series	€ 153,382 Cash 2023: € 153,382 ▼ 40% vs 2022 (€ 256,926) Unfavourable step	€ 257,221 Cash 2024: € 257,221 ▲ 68% vs 2023 (€ 153,382) Favourable step	€ 291,817 Cash 2025: € 291,817 ▲ 13% vs 2024 (€ 257,221) Favourable step	▲ 13%
Land & buildings	€ 143,688 Land & buildings 2022: € 143,688 First fiscal year in the series	€ 136,938 Land & buildings 2023: € 136,938 ▼ 5% vs 2022 (€ 143,688) Unchanged	€ 130,188 Land & buildings 2024: € 130,188 ▼ 5% vs 2023 (€ 136,938) Unchanged	€ 123,438 Land & buildings 2025: € 123,438 ▼ 5% vs 2024 (€ 130,188) Unchanged	▼ 5%
Retained profit	€ 485,295 Retained profit 2022: € 485,295 First fiscal year in the series	€ 555,933 Retained profit 2023: € 555,933 ▲ 15% vs 2022 (€ 485,295) Favourable step	€ 636,793 Retained profit 2024: € 636,793 ▲ 15% vs 2023 (€ 555,933) Favourable step	€ 679,295 Retained profit 2025: € 679,295 ▲ 7% vs 2024 (€ 636,793) Favourable step	▲ 7%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 8,211 Dividend 2023: € 8,211 Unchanged (€ 0) Unchanged	€ 8,211 Dividend 2024: € 8,211 Unchanged (€ 8,211) Unchanged	€ 8,211 Dividend 2025: € 8,211 Unchanged (€ 8,211) Unchanged
Bank debt	€ 2,454 Bank debt 2022: € 2,454 First fiscal year in the series	€ 25,373 Bank debt 2023: € 25,373 ▲ € 22,919 vs 2022 (€ 2,454) Unfavourable step	€ 20,055 Bank debt 2024: € 20,055 ▼ 21% vs 2023 (€ 25,373) Favourable step	€ 14,559 Bank debt 2025: € 14,559 ▼ 27% vs 2024 (€ 20,055) Favourable step	▼ 27%
Balance sheet total	€ 603,780 Balance sheet total 2022: € 603,780 First fiscal year in the series	€ 701,768 Balance sheet total 2023: € 701,768 ▲ 16% vs 2022 (€ 603,780) Unchanged	€ 783,436 Balance sheet total 2024: € 783,436 ▲ 12% vs 2023 (€ 701,768) Unchanged	€ 829,475 Balance sheet total 2025: € 829,475 ▲ 6% vs 2024 (€ 783,436) Unchanged	▲ 6%
Employees (FTE)	2 Employees (FTE) 2022: 2 First fiscal year in the series	2.4 Employees (FTE) 2023: 2.4 ▲ 0.4 vs 2022 (2) Unchanged	2.2 Employees (FTE) 2024: 2.2 ▼ 0.2 vs 2023 (2.4) Unchanged	2.2 Employees (FTE) 2025: 2.2 Unchanged (2.2) Unchanged

Key figures of PHARMACIE LABAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE LABAR?

What happened at PHARMACIE LABAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 50,713 (▼ 43% vs 2024). filed late Source: NBB ↗
Apr 1, 2007 New establishment in Dinant. KBO
Mar 21, 2007 Start of the company according to the CBE. KBO

In short

From € 82,569 profit in 2022 to € 50,713 profit in 2025.

Paid € 121,579 in corporate taxes since 2022.

Best year ever: 2024, with € 89,070 profit.

On average € 105,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE LABAR? We notify you, reason included.

Follow PHARMACIE LABAR

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

MARIE-HELENE LABAR

PHARMACIE LABAR

Behind PHARMACIE LABAR is MARIE-HELENE LABAR.

See the full network in the app

Directors

According to the 2025 annual accounts

MARIE-HELENE LABAR

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Grande 123

5500 Dinant

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0888.126.753

VAT number

BE 0888.126.753

Registered office

Rue Grande 123, 5500 Dinant

Names & denominations

PHARMACIE LABAR

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

21 March 2007

Peppol

Active · Active since 6 Oct 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE LABAR

Financials

What happened to PHARMACIE LABAR?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions